LABBADIA, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 2.542
EU - Europa 838
AS - Asia 349
AF - Africa 22
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.770
Nazione #
US - Stati Uniti d'America 2.526
IT - Italia 302
UA - Ucraina 139
IN - India 121
SE - Svezia 118
SG - Singapore 115
CN - Cina 104
DE - Germania 89
FI - Finlandia 72
BG - Bulgaria 29
GB - Regno Unito 24
TG - Togo 20
IE - Irlanda 19
AR - Argentina 15
FR - Francia 13
CA - Canada 11
RU - Federazione Russa 11
BE - Belgio 10
MX - Messico 5
RO - Romania 5
HK - Hong Kong 4
NL - Olanda 4
CL - Cile 3
MY - Malesia 2
PL - Polonia 2
UZ - Uzbekistan 2
EU - Europa 1
IL - Israele 1
SC - Seychelles 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 3.770
Città #
Fairfield 412
Ashburn 197
Chandler 195
Woodbridge 186
Houston 166
Seattle 163
Cambridge 131
Rome 131
Wilmington 120
Ann Arbor 116
Princeton 69
Beijing 68
Singapore 60
Plano 58
Jacksonville 57
Lawrence 53
San Paolo di Civitate 51
San Diego 48
Boston 42
Dearborn 37
Sofia 29
Millbury 28
Fremont 27
New York 22
Boardman 20
Lomé 20
Andover 19
Dublin 19
Helsinki 16
Federal 15
Milan 14
Brussels 10
Des Moines 10
Nanjing 9
Falls Church 7
Norwalk 7
Toronto 7
Mannheim 6
San Mateo 6
Bari 5
Kunming 5
Phoenix 5
Santa Clara 5
Bremen 4
Hefei 4
Hong Kong 4
Indiana 4
London 4
Mexico City 4
Washington 4
Bühl 3
West Malling 3
Auburn Hills 2
Chicago 2
Courbevoie 2
Formia 2
Hyderabad 2
Jiaxing 2
Jinan 2
Levis 2
Los Angeles 2
Nanchang 2
Napoli 2
Ottawa 2
Paris 2
Redmond 2
Redwood City 2
Rieti 2
Riva 2
Tashkent 2
Vibo Valentia 2
Wuhan 2
Yellow Springs 2
Zhengzhou 2
Acerra 1
Amsterdam 1
Assèmini 1
Bagnacavallo 1
Berlin 1
Buffalo 1
Cagliari 1
Casoria 1
Changsha 1
Clearwater 1
Como 1
Costa Mesa 1
Cuggiono 1
Fiano Romano 1
Fort Worth 1
Frankfurt am Main 1
Fuzhou 1
Gelsenkirchen 1
Grafing 1
Groningen 1
Gunzenhausen 1
Koper 1
Las Vegas 1
Latina 1
Laurel 1
Le Casine-Perignano-Spinelli 1
Totale 2.775
Nome #
IFN-α promotes rapid human Treg contraction and late Th1-like Treg decrease 148
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic hepatitis C virus infection 144
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism 140
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 111
Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis 101
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress 98
Toward an international consensus - integrating lipoprotein apheresis and new lipid-lowering drugs 96
Similar reduction of cholesterol-adjusted Vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis 92
Overexpression of the vitronectin v10 subunit in patients with nonalcoholic steatohepatitis: Implications for noninvasive diagnosis of NASH 89
Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. 88
Cardiac critical events in myotonic dystrophy: Relationship with the severity of neuromuscular disease 87
null 84
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 82
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease 81
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis 80
Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients 78
Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease 76
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysis 75
Natural history of cardiac involvement in myotonic dystrophy (Steinert's disease): A 15-year follow-up study 74
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI register) 73
Ultrasound evaluation of liver fibrosis: preliminary experience with acoustic structure quantification (ASQ) software 71
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus 69
null 66
Epatite cronica HCV correlata e lichen planus: associazione casuale o possibile interdipendenza? 65
La policistosi epatica massiva a rapida evolutività: Presentazione di un caso clinico 62
Liver fibrosis: what's the beginning of autonomic deficit? 62
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 62
Hypertriglyceridaemia, Postprandial Lipaemia And Non-Hdl Cholesterol. 62
Therapeutic plasma exchange in patients with severe hypertriglyceridemia: A multicenter study 60
Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease 60
PD-L1 negatively regulates CD4(+)CD25(+)Foxp3(+) Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV 56
Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease 56
Immunoadsorption Apheresis and Immunosuppressive Drug Therapy in the Treatment of Complicated HCV-Related Cryoglobulinemia 55
Morphologic left ventricular patterns and prevalence of high-grade ventricular arrhythmias in the normotensive and hypertensive elderly 54
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI registry 53
P825 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH REDUCED SERUM CHOLESTEROL-ADJUSTED VITAMIN E LEVELS 50
Low serum levels of ldl-cholesterol inversely correlate with oxysterols plasma levels in hcv infected patients 50
A Flulike Sindrome Associated With Interferon Alfa Therapy Retrospective Study in Patients With Chronic Viral Hepatitis C 48
L'epatocarcinoma: Valutazione epidemiologica e clinica di 90 pazienti 48
Lifestyle and global cardiovascular risk: a prospective study on a borderline hypertensive population 48
Severe Hypertriglyceridemia-Related Acute Pancreatitis 46
Severe hypertriglyceridemia-related acute pancreatitis: Myth or reality? 46
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: A clinical and biochemical characterization 45
Association between histological diagnosis of helicobacter pylory and coronary disease: results of a retrospective study 44
Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease 42
Role of echocardiography in Tako-Tsubo cardiomyopathy: case report 42
Skin diseases as extrahepatic manifestations of HCV. Review of some clinical cases. 41
Adrenomedullin assay and its clinical significance. 40
Ormoni sodiomodulanti cardiaci e renali nell'ipertensione arteriosa giovanile. Considerazioni fisiopatologiche e terapeutiche derivate da una esperienza condotta nel Policlinico Militare Celio di Roma 38
La diagnosi tardiva: una inevitabile fatalità o un errato approccio metodologico? La sindrome di Churg-Strauss 37
La terapia dell'ipertensione arteriosa nel controllo del rischio cardiovascolare globale 34
Increased soluble P-selectin levels in hepatitis C virus-related chronic hepatitis: Correlation with viral load 34
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. 33
Nefrotossicità da farmaci 32
Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis. 32
COMPARSA DI REPLICAZIONE VIRALE DURANTE IL TRATTAMENTO CON CYA IN PAZIENTECON ARTRITE REUMATOIDE E POSITIVITÀ PER ANTICORPI ANTI-HCV. 29
Tollerabilità ed effetti collaterali dell'interferone alfa nel trattamento delle epatiti croniche virali 28
Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease 28
CGRP and ET-1 plasma levels in normal subjects 28
Danni epato-biliari da farmaci 27
Pulmonary hypertension second to micro-thrombosis in situ in patient with positive IgG anti-cardiolipin antibodies. A case report 25
L'ipotiroidismo nell'età geriatrica: una diagnosi spesso ritardata 24
Liver Dysfunction Supportive Therapies – From Therapeutic Plasmapheresis to Molecular Adsorbent Recirculating System 24
Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection 23
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 22
Hypersensitivity myocarditis following deferasirox administration 16
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 11
Patterns of infections in older patients acutely admitted to medical wards. data from the REPOSI register 8
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 7
null 5
null 3
Totale 3.948
Categoria #
all - tutte 10.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.645


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020734 0 0 14 41 91 101 132 107 88 81 61 18
2020/2021469 41 43 27 22 4 40 5 28 56 146 44 13
2021/2022766 13 43 58 47 85 19 10 84 58 67 147 135
2022/2023708 130 175 43 64 89 71 5 39 54 0 25 13
2023/2024348 12 45 12 24 27 79 3 19 1 46 43 37
2024/202571 33 38 0 0 0 0 0 0 0 0 0 0
Totale 3.948